Dade Behring restructures debt:
This article was originally published in Clinica
Executive Summary
Dade Behring is to reduce its debt by half by forming a debt-for-equity swap agreement with its banks, bondholders and owners under a voluntary pre-packaged Chapter 11 filing. The Deerfield, Illinois-based company said it is acting in order to "free up its strong underlying operations for increased growth momentum and long-term financial health". Dade says the filing will not affect its day-to-day operations. The company has also arranged for debtor-in-possession financing, with an initial commitment of $95m. Dade expects to emerge from the filing before the end of October 2002.
You may also be interested in...
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.